Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)

N/AApproved For MarketingNCT05164250

Regeneron Pharmaceuticals

Overview

Provide Compassionate Use' of REGN5458 for Patients with Relapsed or Refractory Multiple Myeloma

Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications.

Study Type

EXPANDED_ACCESS

Medical Language ↔ Plain English

Inclusion Criteria: \- Exclusion Criteria: \-

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.